Frier Levitt Senior Counsel Martha M. Rumore, Pharm.D., Esq., authored Chapter 22 of Drug Discovery and Development, Third Edition. This book presents current scientific information for expanding the ability of a multidisciplinary research team to discover and bring new drugs to the marketplace. Dr. Rumore wrote Chapter 22, titled “Intellectual Property in the Drug Discovery Process.” Along with Dr. Rumore’s chapter, this book also greatly expands the focus on the clinical pharmacology, regulatory, and business aspects of bringing new drugs to the market and offers coverage of essential topics for companies involved in drug development.
Martha M. Rumore Pharm.D., Esq., is a pharmacist-attorney in Frier Levitt’s Life Sciences Department. Her practice focuses on healthcare law; Food, Drug and Cosmetic law; pharmacy regulatory issues; PBM issues; and insurance related matters, as well as pharmaceutical and medical device intellectual property including all aspects of patent law. Dr. Rumore has over 15 years of law firm experience in the area of Food, Drug & Cosmetic Law and pharmaceutical intellectual property, counseling on early market opportunities for generic clients particularly in the area of ANDA and 510K applications and all facets of Paragraph IV litigation. Dr. Rumore frequently lectures and has over 200 publications and presentations. This book has joined her impressive array of work in her career.